The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
West Nile virus-induced disruption of the blood–brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases
Open accessAbstract
West Nile virus (WNV) encephalitis is characterized by neuroinflammation, neuronal loss and blood–brain barrier (BBB) disruption. However, the mechanisms associated with the BBB disruption are unclear. Complex interactions between the tight junction proteins (TJP) and the adherens junction proteins (AJP) of the brain microvascular endothelial cells are responsible for maintaining the BBB integrity. Herein, we characterized the relationship between the BBB disruption and expression kinetics of key TJP, AJP and matrix metalloproteinases (MMPs) in the mice brain. A dramatic increase in the BBB permeability and extravasation of IgG was observed at later time points of the central nervous system (CNS) infection and did not precede virus–CNS entry. WNV-infected mice exhibited significant reduction in the protein levels of the TJP ZO-1, claudin-1, occludin and JAM-A, and AJP β-catenin and vascular endothelial cadherin, which correlated with increased levels of MMP-1, -3 and -9 and infiltrated leukocytes in the brain. Further, intracranial inoculation of WNV also demonstrated increased extravasation of IgG in the brain, suggesting the role of virus replication in the CNS in BBB disruption. These data suggest that altered expression of junction proteins is a pathological event associated with WNV infection and may explain the molecular basis of BBB disruption. We propose that WNV initially enters CNS without altering the BBB integrity and later virus replication in the brain initiates BBB disruption, allowing enhanced infiltration of immune cells and contribute to virus neuroinvasion via the ‘Trojan-horse’ route. These data further implicate roles of multiple MMPs in the BBB disruption and strategies to interrupt this process may influence the WNV disease outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
Lanciotti, R. S., Kerst, A. J., Nasci, R. S., Godsey, M. S., Mitchell, C. J., Savage, H. M., Komar, N., Panella, N. A., Allen, B. C., Volpe, K. E., et al. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.11.4066-4071.2000 · Cited by 1,087 · cited 1×
“…previously (Verma et al., 2011). qRT-PCR was conducted using primers and FAM- and TAMRA-labelled probes specific for WNV env region and the standard curve was generated by using RNA extracted from previously titrated WNV dilutions (10 000 to 0.1 p.f.u.) as described by Lanciotti et al. (2000).”
MethodInfluentialBlood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Persidsky, Y., Ramirez, S. H., Haorah, J., & Kanmogne, G. D. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9025-3 · Cited by 922 · cited 4×
“040899 G 2012 SGM Printed in Great Britain 1193 endothelial cells and perivascular astrocytes separated by the basement membrane (Abbott, 2005; Persidsky et al., 2006).”
BackgroundInfluentialNeuronal CXCL10 Directs CD8 + T-Cell Recruitment and Control of West Nile Virus Encephalitis
Klein, R. S., Lin, E., Zhang, B., Luster, A. D., Tollett, J., Samuel, M. A., Engle, M., & Diamond, M. S. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11457-11466.2005 · Cited by 424 · cited 2×
“In the mouse model, WNVassociated neurological disease is characterized by disruption of the blood–brain barrier (BBB), increased infiltration of immune cells into the central nervous system (CNS), production of inflammatory cytokines, microglia activation and eventual loss of neurons (Glass et al., 2005; Klein et al.…”
BackgroundLim, J. K., Obara, C. J., Rivollier, A., Pletnev, A. G., Kelsall, B. L., & Murphy, P. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003003 · Cited by 176
Verma, S., Kumar, M., Gurjav, U., Lum, S., & Nerurkar, V. R. (2010) · Virology · doi:10.1016/j.virol.2009.10.036 · Cited by 151
Self-citationMouse Adenovirus Type 1-Induced Breakdown of the Blood-Brain Barrier
Gralinski, L. E., Ashley, S. L., Dixon, S. D., & Spindler, K. R. (2009) · Journal of Virology · doi:10.1128/jvi.00954-09 · Cited by 70
Cited by
Neurologic alterations due to respiratory virus infections
Bohmwald, K., Gálvez, N. M. S., Ríos, M., & Kalergis, A. M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00386 · Cited by 636
“This event is a consequence of a systemic infection that releases inflammatory mediators—such as cytokines and chemokines—besides the matrix metalloproteinase (MMP; Roe et al., 2012).”
BackgroundThe dynamic blood–brain barrier
Keaney, J., & Campbell, M. (2015) · The FEBS Journal · doi:10.1111/febs.13412 · Cited by 616
Claudin-5: gatekeeper of neurological function
Greene, C., Hanley, N., & Campbell, M. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0123-z · Cited by 583
Buzhdygan, T. P., DeOre, B. J., Baldwin-Leclair, A., Bullock, T. A., McGary, H. M., Khan, J. A., Razmpour, R., Hale, J. F., Galie, P. A., Potula, R., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105131 · Cited by 507
Ruzek, D., Avšič Županc, T., Borde, J., Chrdle, A., Eyer, L., Karganova, G., Kholodilov, I., Knap, N., Kozlovskaya, L., Matveev, A., et al. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.01.014 · Cited by 414
Metadata
- Authors
- Roe, K., Kumar, M., Lum, S., Orillo, B., Nerurkar, V. R., & Verma, S.
- Venue
- Journal of General Virology
- Publisher
- Microbiology Society
- Published
- 2012-06-01
- Volume
- 93
- Issue
- 6
- Pages
- 1193-1203
- ISSN
- 0022-1317 (ISSN-L)
- 1465-2099
- OpenAlex
- W2161039036
- Cited by
- 185
- References
- 7
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.